{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:16:17Z","timestamp":1794834977137,"version":"4.9.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001719","name":"Netherlands Institute for Advanced Study in the Humanities and Social Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leading biological hypotheses propose that biological changes may underlie major depressive disorder onset and relapse\/recurrence. Here, we investigate if there is prospective evidence for biomarkers derived from leading theories. We focus on neuroimaging, gastrointestinal factors, immunology, neurotrophic factors, neurotransmitters, hormones, and oxidative stress. Searches were performed in Pubmed, Embase and PsychInfo for articles published up to 06\/2019. References and citations of included articles were screened to identify additional articles. Inclusion criteria were having an MDD diagnosis as outcome, a biomarker as predictor, and prospective design search terms were formulated accordingly. PRISMA guidelines were applied. Meta-analyses were performed using a random effect model when three or more comparable studies were identified, using a random effect model. Our search resulted in 67,464 articles, of which 75 prospective articles were identified on: Neuroimaging (<jats:italic>N<\/jats:italic>\u2009=\u200924), Gastrointestinal factors (<jats:italic>N<\/jats:italic>\u2009=\u20091), Immunology (<jats:italic>N<\/jats:italic>\u2009=\u20098), Neurotrophic (<jats:italic>N<\/jats:italic>\u2009=\u20092), Neurotransmitters (<jats:italic>N<\/jats:italic>\u2009=\u20091), Hormones (<jats:italic>N<\/jats:italic>\u2009=\u200939), Oxidative stress (<jats:italic>N<\/jats:italic>\u2009=\u20091). Meta-analyses on brain volumes and immunology markers were not significant. Only cortisol (<jats:italic>N<\/jats:italic>\u2009=\u200919, OR\u2009=\u20091.294,<jats:italic>p<\/jats:italic>\u2009=\u20090.024) showed a predictive effect on onset\/relapse\/recurrence of MDD, but not on time until MDD onset\/relapse\/recurrence. However, this effect disappeared when studies including participants with a baseline clinical diagnosis were removed from the analyses. Other studies were too heterogeneous to compare. Thus, there is a lack of evidence for leading biological theories for onset and maintenance of depression. Only cortisol was identified as potential predictor for MDD, but results are influenced by the disease state. High-quality (prospective) studies on MDD are needed to disentangle the etiology and maintenance of MDD.<\/jats:p>","DOI":"10.1038\/s41380-019-0585-z","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T18:03:02Z","timestamp":1574186582000},"page":"321-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":407,"title":["Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"25","author":[{"given":"Mitzy","family":"Kennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Gerritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-8604","authenticated-orcid":false,"given":"Marije","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alishia","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"Cuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudi","family":"Bockting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"585_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"585_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","volume":"370","author":"S Moussavi","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851\u20138.","journal-title":"Lancet"},{"key":"585_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jad.2012.11.008","volume":"147","author":"F Hardeveld","year":"2013","unstructured":"Hardeveld F, Spijker J, De Graaf R, Hendriks SM, Licht CMM, Nolen WA, et al. Recurrence of major depressive disorder across different treatment settings: results from the NESDA study. J Affect Disord. 2013;147:225\u201331.","journal-title":"J Affect Disord"},{"key":"585_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1017\/S0033291709991036","volume":"40","author":"TE Moffitt","year":"2010","unstructured":"Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk G, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010;40:899\u2013909.","journal-title":"Psychol Med"},{"key":"585_CR5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1176\/ajp.156.7.1000","volume":"156","author":"TI Mueller","year":"1999","unstructured":"Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156:1000\u20136.","journal-title":"Am J Psychiatry"},{"key":"585_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366.","journal-title":"Lancet"},{"key":"585_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/npp.2011.306","volume":"37","author":"J Undurraga","year":"2012","unstructured":"Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology. 2012;37:851\u201364.","journal-title":"Neuropsychopharmacology"},{"key":"585_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1176\/appi.ajp.2009.10030434","volume":"167","author":"V Krishnan","year":"2010","unstructured":"Krishnan V, Nestler EJ. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry. 2010;167:1305\u201320.","journal-title":"Am J Psychiatry"},{"key":"585_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","volume":"34","author":"EJ Nestler","year":"2002","unstructured":"Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13\u201325.","journal-title":"Neuron"},{"key":"585_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/sj.npp.1301408","volume":"33","author":"TE Schlaepfer","year":"2008","unstructured":"Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33:368\u201377.","journal-title":"Neuropsychopharmacology"},{"key":"585_CR11","doi-asserted-by":"crossref","unstructured":"Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci (Regul Ed). 2012;16:61\u201371.","DOI":"10.1016\/j.tics.2011.12.011"},{"key":"585_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-017-0138-2","volume":"16","author":"CJK Wallace","year":"2017","unstructured":"Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017;16:14.","journal-title":"Ann Gen Psychiatry"},{"key":"585_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4081\/cp.2017.987","volume":"7","author":"M Clapp","year":"2017","unstructured":"Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota\u2019s effect on mental health: the gut-brain axis. Clin Pract. 2017;7:987.","journal-title":"Clin Pract"},{"key":"585_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"585_CR15","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","volume":"7","author":"JH Krystal","year":"2002","unstructured":"Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 2002;7:S71\u201380.","journal-title":"Mol Psychiatry"},{"key":"585_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neubiorev.2015.01.018","volume":"51","author":"PW Andrews","year":"2015","unstructured":"Andrews PW, Bharwani A, Lee KR, Fox M, Thomson JA. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci Biobehav Rev. 2015;51:164\u201388.","journal-title":"Neurosci Biobehav Rev"},{"key":"585_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1017\/S1461145708009309","volume":"11","author":"AR Brunoni","year":"2008","unstructured":"Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11:1169\u201380.","journal-title":"Int J Neuropsychopharmacol"},{"key":"585_CR18","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","volume":"367","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc Lond B, Biol Sci. 2012;367:2475\u201384.","journal-title":"Philos Trans R Soc Lond B, Biol Sci"},{"key":"585_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","volume":"23","author":"F Holsboer","year":"2000","unstructured":"Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23:477\u2013501.","journal-title":"Neuropsychopharmacology"},{"key":"585_CR20","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1017\/S0033291716002828","volume":"47","author":"CN Black","year":"2017","unstructured":"Black CN, Bot M, Scheffer PG. Penninx BWJH. Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort. Psychol Med. 2017;47:936\u201348.","journal-title":"Psychol Med"},{"key":"585_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. 2004;1:182\u20138.","journal-title":"NeuroRx"},{"key":"585_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358:55\u201368.","journal-title":"N Engl J Med"},{"key":"585_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jad.2015.03.045","volume":"180","author":"HM van Loo","year":"2015","unstructured":"van Loo HM, Aggen SH, Gardner CO, Kendler KS. Multiple risk factors predict recurrence of major depressive disorder in women. J Affect Disord. 2015;180:52\u201361.","journal-title":"J Affect Disord"},{"key":"585_CR24","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"585_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"585_CR26","unstructured":"Cuijpers P. Meta-analyses inmental health research: a practical guide. Pim Cuijpers Uitgeverij, Amsterdam, the Netherlands, 2016."},{"key":"585_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"585_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"585_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363.","journal-title":"Biometrics"},{"key":"585_CR30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.psyneuen.2009.12.007","volume":"35","author":"EK Adam","year":"2010","unstructured":"Adam EK, Doane LD, Zinbarg RE, Mineka S, Craske MG, Griffith JW. Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence. Psychoneuroendocrinology. 2010;35:921\u201331.*","journal-title":"Psychoneuroendocrinology"},{"key":"585_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jad.2008.08.003","volume":"115","author":"JJB Allen","year":"2009","unstructured":"Allen JJB, McKnight KM, Moreno FA, Demaree HA, Delgado PL. Alteration of frontal EEG asymmetry during tryptophan depletion predicts future depression. J Affect Disord. 2009;115:189\u201395.*","journal-title":"J Affect Disord"},{"key":"585_CR32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.biopsych.2005.09.008","volume":"59","author":"BC Appelhof","year":"2006","unstructured":"Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, et al. Glucocorticoids and relapse of major depression (dexamethasone\/corticotropin-releasing hormone test in relation to relapse of major depression). Biol Psychiatry. 2006;59:696\u2013701.*","journal-title":"Biol Psychiatry"},{"key":"585_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jad.2018.11.052","volume":"245","author":"E Asselmann","year":"2019","unstructured":"Asselmann E, Kische H, Haring R, Hertel J, Schmidt C-O, Nauck M, et al. Prospective associations of androgens and sex hormone-binding globulin with 12-month, lifetime and incident anxiety and depressive disorders in men and women from the general population. J Affect Disord. 2019;245:905\u201311.*","journal-title":"J Affect Disord"},{"key":"585_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jpsychires.2006.07.007","volume":"41","author":"J-M Aubry","year":"2007","unstructured":"Aubry J-M, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, et al. The DEX\/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. J Psychiatr Res. 2007;41:290\u20134.*","journal-title":"J Psychiatr Res"},{"key":"585_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0924-977X(92)90019-5","volume":"2","author":"CM Banki","year":"1992","unstructured":"Banki CM, Karmacsi L, Bissette G, Nemeroff CB. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacol. 1992;2:107\u201313.*","journal-title":"Eur Neuropsychopharmacol"},{"key":"585_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jamapsychiatry.2014.1604","volume":"72","author":"AC Belden","year":"2015","unstructured":"Belden AC, Barch DM, Oakberg TJ, April LM, Harms MP, Botteron KN, et al. Anterior insula volume and guilt: neurobehavioral markers of recurrence after early childhood major depressive disorder. JAMA Psychiatry. 2015;72:40\u20138.*","journal-title":"JAMA Psychiatry"},{"key":"585_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.psychres.2012.03.044","volume":"200","author":"CLH Bockting","year":"2012","unstructured":"Bockting CLH, Lok A, Visser I, Assies J, Koeter MW, Schene AH, et al. Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5 year prospective study. Psychiatry Res. 2012;200:281\u20137.*","journal-title":"Psychiatry Res"},{"key":"585_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/01.nmd.0000228502.52864.ce","volume":"194","author":"AL Bouhuys","year":"2006","unstructured":"Bouhuys AL, Bos EH, Geerts E, van Os TWDP, Ormel J. The association between levels of cortisol secretion and fear perception in patients with remitted depression predicts recurrence. J Nerv Ment Dis. 2006;194:478\u201384.*","journal-title":"J Nerv Ment Dis"},{"key":"585_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1469-8986.2012.01485.x","volume":"50","author":"JN Bress","year":"2013","unstructured":"Bress JN, Foti D, Kotov R, Klein DN, Hajcak G. Blunted neural response to rewards prospectively predicts depression in adolescent girls. Psychophysiology. 2013;50:74\u201381.*","journal-title":"Psychophysiology"},{"key":"585_CR40","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/00004583-200310000-00013","volume":"42","author":"JV Campo","year":"2003","unstructured":"Campo JV, Dahl RE, Williamson DE, Birmaher B, Perel JM, Ryan ND. Gastrointestinal distress to serotonergic challenge: a risk marker for emotional disorder? J Am Acad Child Adolesc Psychiatry. 2003;42:1221\u20136.*","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"585_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1192\/bjp.bp.113.126250","volume":"204","author":"R Carnegie","year":"2014","unstructured":"Carnegie R, Araya R, Ben-Shlomo Y, Glover V, O\u2019Connor TG, O\u2019Donnell KJ, et al. Cortisol awakening response and subsequent depression: prospective longitudinal study. Br J Psychiatry. 2014;204:137\u201343.*","journal-title":"Br J Psychiatry"},{"key":"585_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0165-0327(89)90010-4","volume":"17","author":"GA Charles","year":"1989","unstructured":"Charles GA, Schittecatte M, Rush AJ, Panzer M, Wilmotte J. Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression. J Affect Disord. 1989;17:271\u20138.*","journal-title":"J Affect Disord"},{"key":"585_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jad.2014.03.023","volume":"163","author":"PO Chocano-Bedoya","year":"2014","unstructured":"Chocano-Bedoya PO, Mirzaei F, O\u2019Reilly EJ, Lucas M, Okereke OI, Hu FB, et al. C-reactive protein, interleukin-6, soluble tumor necrosis factor \u03b1 receptor 2 and incident clinical depression. J Affect Disord. 2014;163:25\u201332.*","journal-title":"J Affect Disord"},{"key":"585_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ajp.2008.09.006","volume":"1","author":"KK Chopra","year":"2008","unstructured":"Chopra KK, Segal ZV, Buis T, Kennedy SH, Levitan RD. Investigating associations between cortisol and cognitive reactivity to sad mood provocation and the prediction of relapse in remitted major depression. Asian J Psychiatr. 2008;1:33\u20136.*","journal-title":"Asian J Psychiatr"},{"key":"585_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.psyneuen.2015.02.004","volume":"55","author":"NL Colich","year":"2015","unstructured":"Colich NL, Kircanski K, Foland-Ross LC, Gotlib IH. HPA-axis reactivity interacts with stage of pubertal development to predict the onset of depression. Psychoneuroendocrinology. 2015;55:94\u2013101.*","journal-title":"Psychoneuroendocrinology"},{"key":"585_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2011.09.023","volume":"71","author":"WE Copeland","year":"2012","unstructured":"Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry. 2012;71:15\u201321.*","journal-title":"Biol Psychiatry"},{"key":"585_CR47","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0006-3223(00)00226-2","volume":"47","author":"JD Coplan","year":"2000","unstructured":"Coplan JD, Wolk SI, Goetz RR, Ryan ND, Dahl RE, Mann JJ, et al. Nocturnal growth hormone secretion studies in adolescents with or without major depression re-examined: integration of adult clinical follow-up data. Biol Psychiatry. 2000;47:594\u2013604.*","journal-title":"Biol Psychiatry"},{"key":"585_CR48","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0006-3223(90)90067-C","volume":"28","author":"JP Cosgriff","year":"1990","unstructured":"Cosgriff JP, Abbott RM, Oakley-Browne MA, Joyce PR. Cortisol hypersecretion predicts early depressive relapse after recovery with electroconvulsive therapy. Biol Psychiatry. 1990;28:1007\u201310.*","journal-title":"Biol Psychiatry"},{"key":"585_CR49","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1017\/S0033291714002001","volume":"45","author":"CG Davey","year":"2015","unstructured":"Davey CG, Whittle S, Harrison BJ, Simmons JG, Byrne ML, Schwartz OS, et al. Functional brain-imaging correlates of negative affectivity and the onset of first-episode depression. Psychol Med. 2015;45:1001\u20139.*","journal-title":"Psychol Med"},{"key":"585_CR50","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.biopsych.2011.03.009","volume":"70","author":"NAS Farb","year":"2011","unstructured":"Farb NAS, Anderson AK, Bloch RT, Segal ZV. Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression. Biol Psychiatry. 2011;70:366\u201372.*","journal-title":"Biol Psychiatry"},{"key":"585_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijdevneu.2015.07.007","volume":"46","author":"LC Foland-Ross","year":"2015","unstructured":"Foland-Ross LC, Sacchet MD, Prasad G, Gilbert B, Thompson PM, Gotlib IH. Cortical thickness predicts the first onset of major depression in adolescence. Int J Dev Neurosci. 2015;46:125\u201331.*","journal-title":"Int J Dev Neurosci"},{"key":"585_CR52","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/0006-3223(95)00068-2","volume":"38","author":"B Franz","year":"1995","unstructured":"Franz B, Kupfer DJ, Miewald JM, Jarrett DB, Grochocinski VJ. Growth hormone secretion timing in depression: clinical outcome comparisons. Biol Psychiatry. 1995;38:720\u20139.*","journal-title":"Biol Psychiatry"},{"key":"585_CR53","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4088\/JCP.v65n0407","volume":"65","author":"T Frodl","year":"2004","unstructured":"Frodl T, Meisenzahl EM, Zetzsche T, H\u00f6hne T, Banac S, Schorr C, et al. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry. 2004;65:492\u20139.*","journal-title":"J Clin Psychiatry"},{"key":"585_CR54","first-page":"423","volume":"33","author":"T Frodl","year":"2008","unstructured":"Frodl T, J\u00e4ger M, Smajstrlova I, Born C, Bottlender R, Palladino T, et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33:423\u201330.*","journal-title":"J Psychiatry Neurosci"},{"key":"585_CR55","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1017\/S0033291717002744","volume":"48","author":"J Glaus","year":"2018","unstructured":"Glaus J, von K\u00e4nel R, Lasserre AM, lok MPF, Vandeleur CL, Castelao E, et al. Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study. Psychol Med. 2018;48:961\u201373.*","journal-title":"Psychol Med"},{"key":"585_CR56","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1192\/bjp.176.2.142","volume":"176","author":"IM Goodyer","year":"2000","unstructured":"Goodyer IM, Herbert J, Tamplin A, Altham PM. First-episode major depression in adolescents. Affective, cognitive and endocrine characteristics of risk status and predictors of onset. Br J Psychiatry. 2000;176:142\u20139.*","journal-title":"Br J Psychiatry"},{"key":"585_CR57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1192\/bjp.177.6.499","volume":"177","author":"IM Goodyer","year":"2000","unstructured":"Goodyer IM, Herbert J, Tamplin A, Altham PM. Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br J Psychiatry. 2000;177:499\u2013504.*","journal-title":"Br J Psychiatry"},{"key":"585_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1192\/bjp.bp.108.054775","volume":"195","author":"IM Goodyer","year":"2009","unstructured":"Goodyer IM, Bacon A, Ban M, Croudace T, Herbert J. Serotonin transporter genotype, morning cortisol and subsequent depression in adolescents. Br J Psychiatry. 2009;195:39\u201345.*","journal-title":"Br J Psychiatry"},{"key":"585_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1192\/bjp.bp.110.077750","volume":"197","author":"IM Goodyer","year":"2010","unstructured":"Goodyer IM, Croudace T, Dudbridge F, Ban M, Herbert J. Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents. Br J Psychiatry. 2010;197:365\u201371.*","journal-title":"Br J Psychiatry"},{"key":"585_CR60","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.psyneuen.2013.03.013","volume":"38","author":"MB Grynderup","year":"2013","unstructured":"Grynderup MB, Kolstad HA, Mikkelsen S, Andersen JH, Bonde JP, Buttensch\u00f8n HN, et al. A two-year follow-up study of salivary cortisol concentration and the risk of depression. Psychoneuroendocrinology. 2013;38:2042\u201350.*","journal-title":"Psychoneuroendocrinology"},{"key":"585_CR61","doi-asserted-by":"publisher","first-page":"e110555","DOI":"10.1371\/journal.pone.0110555","volume":"9","author":"E Haastrup","year":"2014","unstructured":"Haastrup E, Grau K, Eugen-Olsen J, Thorball C, Kessing LV, Ullum H. Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants. PLoS ONE. 2014;9:e110555.*","journal-title":"PLoS ONE"},{"key":"585_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.psyneuen.2014.07.027","volume":"50","author":"F Hardeveld","year":"2014","unstructured":"Hardeveld F, Spijker J, Vreeburg SA, Graaf RD, Hendriks SM, Licht CMM, et al. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder. Psychoneuroendocrinology. 2014;50:62\u201371.*","journal-title":"Psychoneuroendocrinology"},{"key":"585_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1192\/bjp.177.6.505","volume":"177","author":"TO Harris","year":"2000","unstructured":"Harris TO, Borsanyi S, Messari S, Stanford K, Cleary SE, Shiers HM, et al. Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br J Psychiatry. 2000;177:505\u201310.*","journal-title":"Br J Psychiatry"},{"key":"585_CR64","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0022-3956(02)00021-3","volume":"36","author":"M Hatzinger","year":"2002","unstructured":"Hatzinger M, Hemmeter UM, Baumann K, Brand S, Holsboer-Trachsler E. The combined DEX-CRH test in treatment course and long-term outcome of major depression. J Psychiatr Res. 2002;36:287\u201397.*","journal-title":"J Psychiatr Res"},{"key":"585_CR65","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1192\/bjp.bp.111.107037","volume":"201","author":"J Herbert","year":"2012","unstructured":"Herbert J, Ban M, Brown GW, Harris TO, Ogilvie A, Uher R, et al. Interaction between the BDNF gene Val\/66\/Met polymorphism and morning cortisol levels as a predictor of depression in adult women. Br J Psychiatry. 2012;201:313\u20139.*","journal-title":"Br J Psychiatry"},{"key":"585_CR66","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0022-3956(94)90007-8","volume":"28","author":"DB Jarrett","year":"1994","unstructured":"Jarrett DB, Kupfer DJ, Miewald JM, Grochocinski VJ, Franz B. Sleep-related growth hormone secretion is persistently suppressed in women with recurrent depression: a preliminary longitudinal analysis. J Psychiatr Res. 1994;28:211\u201323.*","journal-title":"J Psychiatr Res"},{"key":"585_CR67","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1176\/appi.ajp.157.10.1689","volume":"157","author":"RT Joffe","year":"2000","unstructured":"Joffe RT, Marriott M. Thyroid hormone levels and recurrence of major depression. Am J Psychiatry. 2000;157:1689\u201391.*","journal-title":"Am J Psychiatry"},{"key":"585_CR68","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0006-3223(99)00134-1","volume":"46","author":"TG Johnston","year":"1999","unstructured":"Johnston TG, Kelly CB, Stevenson MR, Cooper SJ. Plasma norepinephrine and prediction of outcome in major depressive disorder. Biol Psychiatry. 1999;46:1253\u20138.*","journal-title":"Biol Psychiatry"},{"key":"585_CR69","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71:1121\u20138.*","journal-title":"JAMA Psychiatry"},{"key":"585_CR70","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1192\/bjp.bp.107.040378","volume":"192","author":"K-T Kronm\u00fcller","year":"2008","unstructured":"Kronm\u00fcller K-T, Pantel J, K\u00f6hler S, Victor D, Giesel F, Magnotta VA, et al. Hippocampal volume and 2-year outcome in depression. Br J Psychiatry. 2008;192:472\u20133.*","journal-title":"Br J Psychiatry"},{"key":"585_CR71","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.nicl.2018.10.004","volume":"20","author":"SA Langenecker","year":"2018","unstructured":"Langenecker SA, Jenkins LM, Stange JP, Chang Y-S, DelDonno SR, Bessette KL, et al. Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression. Neuroimage Clin. 2018;20:1001\u20139.*","journal-title":"Neuroimage Clin"},{"key":"585_CR72","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1037\/abn0000087","volume":"124","author":"J LeMoult","year":"2015","unstructured":"LeMoult J, Ordaz SJ, Kircanski K, Singh MK, Gotlib IH. Predicting first onset of depression in young girls: Interaction of diurnal cortisol and negative life events. J Abnorm Psychol. 2015;124:850\u20139.*","journal-title":"J Abnorm Psychol"},{"key":"585_CR73","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1037\/abn0000101","volume":"124","author":"K Little","year":"2015","unstructured":"Little K, Olsson CA, Youssef GJ, Whittle S, Simmons JG, Y\u00fccel M, et al. Linking the serotonin transporter gene, family environments, hippocampal volume and depression onset: A prospective imaging gene \u00d7 environment analysis. J Abnorm Psychol. 2015;124:834\u201349.*","journal-title":"J Abnorm Psychol"},{"key":"585_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.85","volume":"4","author":"K Little","year":"2014","unstructured":"Little K, Olsson CA, Whittle S, Youssef GJ, Byrne ML, Simmons JG, et al. Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: a longitudinal prospective study. Transl Psychiatry. 2014;4:e445.*","journal-title":"Transl Psychiatry"},{"key":"585_CR75","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.psyneuen.2011.10.005","volume":"37","author":"A Lok","year":"2012","unstructured":"Lok A, Mocking RJT, Ruh\u00e9 HG, Visser I, Koeter MWJ, Assies J, et al. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression. Psychoneuroendocrinology. 2012;37:892\u2013902.*","journal-title":"Psychoneuroendocrinology"},{"key":"585_CR76","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jamapsychiatry.2015.1813","volume":"72","author":"KE Lythe","year":"2015","unstructured":"Lythe KE, Moll J, Gethin JA, Workman CI, Green S, Lambon Ralph MA, et al. Self-blame-selective hyperconnectivity between anterior temporal and subgenual cortices and prediction of recurrent depressive episodes. JAMA Psychiatry. 2015;72:1119\u201326.*","journal-title":"JAMA Psychiatry"},{"key":"585_CR77","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.nicl.2017.12.011","volume":"17","author":"J Macoveanu","year":"2018","unstructured":"Macoveanu J, Baar\u00e9 W, Madsen KH, Kessing LV, Siebner HR, Vinberg M. Risk for affective disorders is associated with greater prefrontal gray matter volumes: a prospective longitudinal study. Neuroimage Clin. 2018;17:786\u201393.*","journal-title":"Neuroimage Clin"},{"key":"585_CR78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0022-3956(89)90005-8","volume":"23","author":"AJ Mander","year":"1989","unstructured":"Mander AJ, Rubin RT, Copolov DL, Poland RE. The predictive power of the salivary cortisol dexamethasone suppression test for three-year outcome in major depressive illness. J Psychiatr Res. 1989;23:151\u20136.*","journal-title":"J Psychiatr Res"},{"key":"585_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.psyneuen.2015.05.006","volume":"59","author":"RJT Mocking","year":"2015","unstructured":"Mocking RJT, Pellikaan CM, Lok A, Assies J, Ruh\u00e9 HG, Koeter MW, et al. DHEAS and cortisol\/DHEAS-ratio in recurrent depression: state, or trait predicting 10-year recurrence? Psychoneuroendocrinology. 2015;59:91\u2013101.*","journal-title":"Psychoneuroendocrinology"},{"key":"585_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jad.2012.05.059","volume":"143","author":"MC Morris","year":"2012","unstructured":"Morris MC, Rao U, Garber J. Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators. J Affect Disord. 2012;143:223\u201330.*","journal-title":"J Affect Disord"},{"key":"585_CR81","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1017\/S0033291716000519","volume":"46","author":"T Nickson","year":"2016","unstructured":"Nickson T, Chan SWY, Papmeyer M, Romaniuk L, Macdonald A, Stewart T, et al. Prospective longitudinal voxel-based morphometry study of major depressive disorder in young individuals at high familial risk. Psychol Med. 2016;46:2351\u201361.*","journal-title":"Psychol Med"},{"key":"585_CR82","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1192\/bjp.bp.113.129965","volume":"204","author":"NL Nixon","year":"2014","unstructured":"Nixon NL, Liddle PF, Nixon E, Worwood G, Liotti M, Palaniyappan L. Biological vulnerability to depression: linked structural and functional brain network findings. Br J Psychiatry. 2014;204:283\u20139.*","journal-title":"Br J Psychiatry"},{"key":"585_CR83","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1037\/a0022940","volume":"120","author":"R Nusslock","year":"2011","unstructured":"Nusslock R, Shackman AJ, Harmon-Jones E, Alloy LB, Coan JA, Abramson LY. Cognitive vulnerability and frontal brain asymmetry: common predictors of first prospective depressive episode. J Abnorm Psychol. 2011;120:497\u2013503.*","journal-title":"J Abnorm Psychol"},{"key":"585_CR84","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpsychires.2007.01.006","volume":"42","author":"T Owashi","year":"2008","unstructured":"Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K. Relationships of DEX\/CRH and GHRH test results to the outcome of depression\u2013preliminary results suggest the GHRH test may predict relapse after discharge. J Psychiatr Res. 2008;42:356\u201364.*","journal-title":"J Psychiatr Res"},{"key":"585_CR85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biopsych.2014.10.018","volume":"78","author":"M Papmeyer","year":"2015","unstructured":"Papmeyer M, Giles S, Sussmann JE, Kielty S, Stewart T, Lawrie SM, et al. Cortical thickness in individuals at high familial risk of mood disorders as they develop major depressive disorder. Biol Psychiatry. 2015;78:58\u201366.*","journal-title":"Biol Psychiatry"},{"key":"585_CR86","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pscychresns.2015.12.009","volume":"248","author":"M Papmeyer","year":"2016","unstructured":"Papmeyer M, Sussmann JE, Stewart T, Giles S, Centola JG, Zannias V, et al. Prospective longitudinal study of subcortical brain volumes in individuals at high familial risk of mood disorders with or without subsequent onset of depression. Psychiatry Res Neuroimaging. 2016;248:119\u201325.*","journal-title":"Psychiatry Res Neuroimaging"},{"key":"585_CR87","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","volume":"197","author":"JA Pasco","year":"2010","unstructured":"Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry. 2010;197:372\u20137.*","journal-title":"Br J Psychiatry"},{"key":"585_CR88","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00406-017-0812-z","volume":"268","author":"MA Pasquali","year":"2017","unstructured":"Pasquali MA, Harlow BL, Soares CN, Otto MW, Cohen LS, Minuzzi L, et al. A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women. Eur Arch Psychiatry Clin Neurosci. 2017;268:771\u201381.*","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"585_CR89","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pnpbp.2009.01.008","volume":"33","author":"L Pintor","year":"2009","unstructured":"Pintor L, Torres X, Navarro V, Martinez de Osaba MAJ, Matrai S, Gast\u00f3 C. Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:463\u20139.*","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"585_CR90","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/08039488.2012.700733","volume":"67","author":"L Pintor","year":"2013","unstructured":"Pintor L, Torres X, Bailles E, Navarro V, de Osaba MJM, Belmonte A, et al. CRF test in melancholic depressive patients with partial versus complete relapses: a 2-year follow-up study. Nord J Psychiatry. 2013;67:177\u201384.*","journal-title":"Nord J Psychiatry"},{"key":"585_CR91","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.biopsych.2009.10.017","volume":"67","author":"U Rao","year":"2010","unstructured":"Rao U, Chen L-A, Bidesi AS, Shad MU, Thomas MA, Hammen CL. Hippocampal changes associated with early-life adversity and vulnerability to depression. Biol Psychiatry. 2010;67:357\u201364.*","journal-title":"Biol Psychiatry"},{"key":"585_CR92","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/npp.2009.27","volume":"34","author":"U Rao","year":"2009","unstructured":"Rao U, Hammen CL, Poland RE. Risk markers for depression in adolescents: sleep and HPA measures. Neuropsychopharmacology. 2009;34:1936\u201345.*","journal-title":"Neuropsychopharmacology"},{"key":"585_CR93","first-page":"141","volume":"49","author":"U Rao","year":"2010","unstructured":"Rao U, Hammen CL, Poland RE. Longitudinal course of adolescent depression: neuroendocrine and psychosocial predictors. J Am Acad Child Adolesc Psychiatry. 2010;49:141\u201351.*","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"585_CR94","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jad.2017.07.016","volume":"222","author":"DA Rudaz","year":"2017","unstructured":"Rudaz DA, Vandeleur CL, Gebreab SZ, Gholam-Rezaee M, Strippoli M-PF, Lasserre AM, et al. Partially distinct combinations of psychological, metabolic and inflammatory risk factors are prospectively associated with the onset of the subtypes of Major Depressive Disorder in midlife. J Affect Disord. 2017;222:195\u2013203.*","journal-title":"J Affect Disord"},{"key":"585_CR95","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/da.22522","volume":"33","author":"M Serra-Blasco","year":"2016","unstructured":"Serra-Blasco M, de Diego-Adeli\u00f1o J, Vives-Gilabert Y, Trujols J, Puigdemont D, Carceller-Sindreu M, et al. Naturalistic course of major depressive disorder predicted by clinical and structural neuroimaging data: a 5-year follow-up. Depress Anxiety. 2016;33:1055\u201364.*","journal-title":"Depress Anxiety"},{"key":"585_CR96","first-page":"409","volume":"34","author":"J Tsuru","year":"2013","unstructured":"Tsuru J, Ishitobi Y, Ninomiya T, Kanehisa M, Imanaga J, Inoue A, et al. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge. Neuro Endocrinol Lett. 2013;34:409\u201317.*","journal-title":"Neuro Endocrinol Lett"},{"key":"585_CR97","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.psyneuen.2013.09.007","volume":"39","author":"M Vinberg","year":"2014","unstructured":"Vinberg M, Miskowiak K, Kessing LV. Brain Derived Neurotrophic Factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder. Psychoneuroendocrinology. 2014;39:179\u201383.*","journal-title":"Psychoneuroendocrinology"},{"key":"585_CR98","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1017\/S0033291712001213","volume":"43","author":"S Vrshek-Schallhorn","year":"2013","unstructured":"Vrshek-Schallhorn S, Doane LD, Mineka S, Zinbarg RE, Craske MG, Adam EK. The cortisol awakening response predicts major depression: predictive stability over a 4-year follow-up and effect of depression history. Psychol Med. 2013;43:483\u201393.*","journal-title":"Psychol Med"},{"key":"585_CR99","doi-asserted-by":"publisher","first-page":"e57357","DOI":"10.1371\/journal.pone.0057357","volume":"8","author":"HC Whalley","year":"2013","unstructured":"Whalley HC, Sussmann JE, Romaniuk L, Stewart T, Papmeyer M, Sprooten E, et al. Prediction of depression in individuals at high familial risk of mood disorders using functional magnetic resonance imaging. PLoS ONE. 2013;8:e57357.*","journal-title":"PLoS ONE"},{"key":"585_CR100","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1017\/S0033291714002256","volume":"45","author":"HC Whalley","year":"2015","unstructured":"Whalley HC, Sussmann JE, Romaniuk L, Stewart T, Kielty S, Lawrie SM, et al. Dysfunction of emotional brain systems in individuals at high risk of mood disorder with depression and predictive features prior to illness. Psychol Med. 2015;45:1207\u201318.*","journal-title":"Psychol Med"},{"key":"585_CR101","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1017\/S0033291716002567","volume":"47","author":"CI Workman","year":"2017","unstructured":"Workman CI, Lythe KE, McKie S, Moll J, Gethin JA, Deakin JFW, et al. A novel resting-state functional magnetic resonance imaging signature of resilience to recurrent depression. Psychol Med. 2017;47:597\u2013607.*","journal-title":"Psychol Med"},{"key":"585_CR102","doi-asserted-by":"crossref","unstructured":"Zimmerman M, Coryell W, Pfohl B. Prognostic validity of the dexamethasone suppression test: results of a six-month prospective follow-up. The American Journal of Psychiatry 1987;144:212\u2013214.*","DOI":"10.1176\/ajp.144.2.212"},{"key":"585_CR103","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1176\/ajp.156.6.949","volume":"156","author":"AW Zobel","year":"1999","unstructured":"Zobel AW, Yassouridis A, Frieboes RM, Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry. 1999;156:949\u201351.*","journal-title":"Am J Psychiatry"},{"key":"585_CR104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-3956(01)00013-9","volume":"35","author":"AW Zobel","year":"2001","unstructured":"Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M. Cortisol response in the combined dexamethasone\/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res. 2001;35:83\u201394.*","journal-title":"J Psychiatr Res"},{"key":"585_CR105","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neubiorev.2017.11.012","volume":"84","author":"VI M\u00fcller","year":"2018","unstructured":"M\u00fcller VI, Cieslik EC, Laird AR, Fox PT, Radua J, Mataix-Cols D, et al. Ten simple rules for neuroimaging meta-analysis. Neurosci Biobehav Rev. 2018;84:151\u201361.","journal-title":"Neurosci Biobehav Rev"},{"key":"585_CR106","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.biopsych.2017.07.002","volume":"83","author":"MI Geerlings","year":"2018","unstructured":"Geerlings MI, Gerritsen L. Reply to: late-life depression, cortisol, and the hippocampus: on the need to consider depressive, hippocampal, and pharmacological complexities. Biol Psychiatry. 2018;83:e25.","journal-title":"Biol Psychiatry"},{"key":"585_CR107","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","volume":"73","author":"C Stetler","year":"2011","unstructured":"Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011;73:114\u201326.","journal-title":"Psychosom Med"},{"key":"585_CR108","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1037\/0033-2909.133.1.25","volume":"133","author":"GE Miller","year":"2007","unstructured":"Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull. 2007;133:25\u201345.","journal-title":"Psychol Bull"},{"key":"585_CR109","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.mp.4001949","volume":"12","author":"HG Ruh\u00e9","year":"2007","unstructured":"Ruh\u00e9 HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry. 2007;12:331\u201359.","journal-title":"Mol Psychiatry"},{"key":"585_CR110","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1001\/jamapsychiatry.2017.3610","volume":"75","author":"A Etkin","year":"2018","unstructured":"Etkin A. Addressing the causality gap in human psychiatric neuroscience. JAMA Psychiatry. 2018;75:3\u20134.","journal-title":"JAMA Psychiatry"},{"key":"585_CR111","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biopsych.2010.03.018","volume":"68","author":"P-Y Lin","year":"2010","unstructured":"Lin P-Y, Huang S-Y, Su K-P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010;68:140\u20137.","journal-title":"Biol Psychiatry"},{"key":"585_CR112","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","volume":"50","author":"NR Wray","year":"2018","unstructured":"Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668\u201381.","journal-title":"Nat Genet"},{"key":"585_CR113","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2018.05.020","volume":"103","author":"CA K\u00f6hler","year":"2018","unstructured":"K\u00f6hler CA, Evangelou E, Stubbs B, Solmi M, Veronese N, Belbasis L, et al. Mapping risk factors for depression across the lifespan: an umbrella review of evidence from meta-analyses and Mendelian randomization studies. J Psychiatr Res. 2018;103:189\u2013207.","journal-title":"J Psychiatr Res"},{"key":"585_CR114","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1176\/appi.ajp.157.10.1552","volume":"157","author":"PF Sullivan","year":"2000","unstructured":"Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157:1552\u201362.","journal-title":"Am J Psychiatry"},{"key":"585_CR115","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/2167702616628523","volume":"4","author":"AT Beck","year":"2016","unstructured":"Beck AT, Bredemeier K. A unified model of depression: integrating clinical, cognitive, biological, and evolutionary perspectives. Clin Psychological Sci. 2016;4:596\u2013619.","journal-title":"Clin Psychological Sci"},{"key":"585_CR116","doi-asserted-by":"crossref","unstructured":"Marlies E. Brouwer, Alishia D. Williams, Mitzy Kennis, Zhongfang Fu, Nicola S. Klein, Pim Cuijpers, Claudi L.H. Bockting. Psychological theories of depressive relapse and recurrence: A systematic review and meta-analysis of prospective studies. Clinical Psychology Review:101773. (2019).","DOI":"10.1016\/j.cpr.2019.101773"},{"key":"585_CR117","doi-asserted-by":"crossref","unstructured":"Nixon NL, Liddle PF, Worwood G, Liotti M, Nixon E. Prefrontal cortex function in remitted major depressive disorder. Psychological Medicine. 2013;43:1219\u20131230.","DOI":"10.1017\/S0033291712002164"},{"key":"585_CR118","doi-asserted-by":"crossref","unstructured":"Mocking, R.J.T., Ruh\u00e9, H.G., Assies, J., et al. Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression. Psychoneuroendocrinology. 2013;38:1607\u20131617.","DOI":"10.1016\/j.psyneuen.2013.01.013"},{"key":"585_CR119","unstructured":"(References denoted by an asterisk are included in the narrative synthesis and\/or meta-analyses)."}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0585-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:10Z","timestamp":1684616470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-019-0585-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1038\/s41380-019-0585-z","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}